Docaravimab + Miromavimab
Information about Docaravimab + Miromavimab
Docaravimab + Miromavimab Uses
Docaravimab+Miromavimab is used in the treatment of Rabies.
How Docaravimab + Miromavimab works
Rabies is a viral infection caused by the rabies virus which primarily affects the nervous system. Once the virus enters the body through a bite from an infected animal, it travels along nerve fibers to the central nervous system, including the brain. There, it can cause severe neurological symptoms and, ultimately, death if left untreated. Docaravimab + Miromavimab contains two antibodies: docaravimab and miromavimab. These antibodies bind to the rabies virus and prevent it from entering and infecting nerve cells and other cells in the body. This interruption of the virus's ability to replicate and spread within the body is crucial for halting the progression of rabies infection.
Common side effects of Docaravimab + Miromavimab
Injection site reactions (pain, swelling, redness)
Available Medicine for Docaravimab + Miromavimab
TwinrabCadila Healthcare Limited
₹1697 to ₹30852 variant(s)
Expert advice for Docaravimab + Miromavimab
- All cases of rabies exposure should be treated immediately for the prevention of clinical symptoms and death.
- Docaravimab + Miromavimab is prescribed for post-exposure risk prevention after contact with an infected animal or an animal suspected to have rabies infection.
- No skin sensitivity test is required.
- Docaravimab + Miromavimab should be given by a trained healthcare professional.
- Follow the recommended dosing schedule.